Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802

Corticosteroids are the accepted primary therapy for acute graft-versus-host disease (GVHD), but durable responses are seen in only about half of the patients. Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0802, a phase 3 multicenter randomized double-blinded trial, was designed to t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood
Autores principales: Bolaños-Meade, Javier, Logan, Brent R., Alousi, Amin M., Antin, Joseph H., Barowski, Kate, Carter, Shelly L., Goldstein, Steven C., Hexner, Elizabeth O., Horowitz, Mary M., Lee, Stephanie J., Levine, John E., MacMillan, Margaret L., Martin, Paul J., Mendizabal, Adam M., Nakamura, Ryotaro, Pasquini, Marcelo C., Weisdorf, Daniel J., Westervelt, Peter, Ho, Vincent T.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2014
Materias:
Clinical Trials and Observations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4239331/
https://ncbi.nlm.nih.gov/pubmed/25170121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-06-577023
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares